Skip to content
healthcare.dev

PALSONIFY

NDC 84015-920, PALTUSOTINE, tablet, film coated, from Crinetics Pharmaceuticals, Inc..

Product NDC
84015-920
Status
Listed
Labeler
Crinetics Pharmaceuticals, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219070
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/84015-920 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PALTUSOTINE HYDROCHLORIDE20 mg/1
Package NDCNDC-11Package
84015-920-608401509206060 TABLET, FILM COATED in 1 BOTTLE (84015-920-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8a6d2ce0-a621-4ee7-983c-977cd948ff4d

Use it

Look up 84015-920 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/84015-920 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 84015-920. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.